Anxiety And Depression in Chronic Kidney Disease (CKD) Patients in The Initial Phase of Hemodialysis Therapy (original) (raw)
Related papers
Depression and anxiety among patients with chronic kidney disease receiving hemodialysis
2018
Introduction: Depression and anxiety are among the most common comorbid illnesses in people with end-stage renal disease. The current study aimed to assess the actual pattern of symptoms of depression and anxiety in the hemodialysis population in Qazvin. Methods: For this purpose, 80 individuals (40 hemodialysis patients and 40 individuals as the control group) have participated in this study. All participants completed Beck Depression Inventory and Cattell Anxiety Inventory. Additionally, clinical status, socioeconomic and demographic variables of patients have been collected and analyzed by appropriate statistical methods (independent T-test and chi-square test). Results: In examining the variables of depression in terms of severe and mild depression, there have been 14 hemodialysis patients (35%) versus 34 (85%) individuals from the control group, in terms of moderate depression-severe index there has been 26 (65%) versus 6 (15%). Regarding the anxiety variable in terms of the ma...
Applied Nursing Research, 2018
Background: Dialysis is a lifelong treatment required by end stage renal disease patients who are not able to undergo renal transplantation. Dialysis impacts the patients' quality of life drastically, increasing the risk of mortality. Depression and anxiety are commonly reported among dialysis patients, but their prevalence and correlates vary by sociocultural context. Objective: The aim of this study is to examine the prevalence of anxiety and depression and associated factors among patients receiving hemodialysis at a major tertiary referral medical center in Lebanon that receives patients from all over the country. Design: A cross-sectional, descriptive design was used. Methods: Ninety patients receiving hemodialysis were targeted using convenience sampling, with a final sample size of 83 patients. The patients were interviewed while undergoing their dialysis session using the Hospital Anxiety and Depression Scale, and asked demographic and clinical questions. Results: The majority of participants were married men over 60 years of age; 48% achieved high school education. Depression was prevalent in 40.8% and anxiety in 39.6%, with 20 patients (24.1%) having both conditions. Although 24.1% self-reported anxiety symptoms, only 2.4% were taking anxiolytics. Illiterate patients had significantly higher depression scores than those with higher levels of education (p = 0.021). Patients who were living with their family had higher anxiety scores than those living alone (p = 0.014). Conclusion: Anxiety and depression are underdiagnosed and undertreated in Lebanese dialysis patients. Screening and appropriate referral to mental health specialists are needed.
Contagion, 2023
This study is an analytical descriptive study with a cross-sectional design that aims to determine the proportion and level of depression and anxiety of patients, as well as the relationship between the length of hemodialysis therapy with depression and anxiety of patients with Chronic Kidney Disease undergoing hemodialysis therapy at the Hemodialysis Installation of Dr. Moewardi Surakarta Regional General Hospital. Samples in this study were taken by purposive sampling. The sample in this study amounted to 31 research subjects. The specified data analysis is a Chi-square test analysis to test the relationship between variables. The percentage of anxiety among Chronic Kidney Disease patients receiving hemodialysis treatment at Dr. Moewardi Surakarta Regional General Hospital's Hemodialysis Facility is 29%, while the percentage of depressed patients with Chronic Kidney Disease undergoing hemodialysis therapy at the same facility is 41.9%. It has been determined that there is no discernible correlation between the duration of hemodialysis therapy and the emergence of anxiety and depression in patients with Chronic Kidney Disease at this specific healthcare center. To gain a more comprehensive understanding, additional research is warranted to investigate other factors linked to anxiety and depression in patients with chronic kidney disease undergoing hemodialysis therapy. Furthermore, there is a pressing need for the implementation of a screening program for Chronic Kidney Disease patients undergoing hemodialysis therapy at hospitals, with a potential referral to the Department of Psychiatry for the assessment and management of any mental symptoms that may arise.
International Urology and Nephrology
Purpose The aims of the study are to explore the prevalence and risk factors of anxiety and depression in hemodialysis (HD) patients and to study their relationship with quality of life (QOL). Methods This cross-sectional study involved 298 HD patients. Sociodemographic, clinical, and laboratory data of the patients were obtained from their records. Anxiety and depression were assessed by utilizing Hospital Anxiety and Depression Scale (HADS). In addition, QOL of the patients were evaluated by fulfilling the Kidney Disease Quality of Life-36. Results This study included 298 HD patients (male 59.1%) with a median age of 49 years. Abnormal and borderline cases of anxiety were recognized in 49.6%, 26.2% of the patients, respectively, while depression cases and borderline cases were identified in 55 and 28.2% of the patients, respectively. Percentages of females (41 and 48% vs 26.4%, respectively), and patients who were not working (92.3 and 93.9% vs 72.2%, respectively) increased signi...
Course of Depression and Anxiety Diagnosis in Patients Treated with Hemodialysis
Clinical Journal of the American Society of Nephrology, 2008
Background and objectives: There is growing identification of the need to seriously study the psychiatric presentations of end-stage renal disease patients treated with hemodialysis. This study reports on the course of depression and anxiety diagnoses and their impact on quality of life and health status. Design, setting, participants, & measurements: The 16-mo course of psychiatric diagnoses in 50 end-stage renal disease patients treated with hemodialysis was measured by structured clinical interview. Results: Three different pathways were identified: one subset of patients not having a psychiatric diagnosis at either baseline or 16-mo follow-up (68% for depression, 51% for anxiety), one group having an intermittent course (21% for depression, 34% for anxiety), and one group having a persistent course (11% for depression, 15% for anxiety), with diagnoses at both time 1 and time 2. For depression, the people with the persistent course showed marked decreases in quality of life and self-reported health status compared with the nondepressed and intermittently depressed cohorts. The most powerful predictor of depression at time 2 is degree of depressive affect at time 1(P < 0.05). Conclusions: Patients at risk for short-and long-term complications of depression can be potentially identified by high levels of depressive affect even at a single time point. As nearly 20% of the sample had chronic depression or anxiety, identifying a psychiatric diagnosis in hemodialysis patients and then offering treatment are important because, in the absence of intervention, psychiatric disorders are likely to persist in a substantial proportion of patients.
The anxiety symptoms among chronic kidney disease patients who undergo hemodialysis therapy
International Journal of Public Health Science (IJPHS)
Unresolved anxiety can lead to some impact on which a person tends to have a negative assessment of the meaning of life, decreased quality of life, emotional changes such as chronic depression and psychosis disorders. The general objective in this research is to find out the symptoms of anxiety symptoms of chronic kidney disease patients undergo hemodialysis. This research employed cross sectional design. This study used non-probability sampling type quota sampling. Sample was calculated using the Slovin formula obtained a sample size of 171. The proportion of patient with chronic kidney disease treated with hemodialysis based on the anxiety level resulting mild anxiety (86.5%) and moderate anxiety (13.5%). There are symptoms of anxiety symptoms in patients with chronic kidney disease undergoing hemodialysis.
The Impact of Anxiety and Depression on the Quality of Life of Hemodialysis Patients
Global Journal of Health Science, 2015
PURPOSE: This study was to explore the impact of anxiety and depression on the quality of life of hemodialysis patients. MATERIAL & METHODS: The sample studied consisted of 395 hemodialysis patients. Data was collected by the completion of a specially designed questionnaire for the needs of the present study which apart from socio-demographic and clinical, it also included HADS scale to assess the level of anxiety and depression as well as the scale Missoula-VITAS Quality of Life Index (MVQOLI) to assess patients’ quality of life. RESULTS: The results of this study showed that 47.8% had high anxiety levels and 38.2% had high levels of depression. The average total score of quality of life was found to be 17.14. It was also shown that the total score of quality of life presented statistically significant association with family status (p=0.007), educational level (p<0.001), the number of children (p=0.001), patients’ adherence to doctors' orders (p=0.003) and proposed diet (p=...
Journal of Evidence Based Medicine and Healthcare
BACKGROUND The prevalence of chronic kidney disease (CKD) has steadily increased over the past few decades. Multiple factors including improvements in life expectancy and increasing prevalence of comorbid illness such as hypertension and diabetes have contributed to this. Most common form of treatment in CKD patients is haemodialysis. Depression and anxiety disorders are common psychological problem among haemodialysis patients. However, there is minimal literature on the prevalence of anxiety and depressive symptoms and their impact on patient's quality of life and treatment outcomes. Quality of life (QoL) is another neglected aspect of CKD care, as the available resources are often used to address the general medical needs. The current study aims to assess the prevalence of symptoms of depression and anxiety in patients of haemodialysis and the perceived quality of life in these patients. METHODS A cross sectional observational study was done in 120 haemodialysis patients after approval from Institutional Ethics Committee and after getting informed consent from patients. The study was done in the dialysis unit under Department of Nephrology, Travancore Medical College, Kollam. Patients were screened by a semi-structured questionnaire which includes the patients' socio-demographic data. Hospital Anxiety and Depression Scale (HADS) was used to assess severity of anxiety and depressive symptoms. The Quality of Life (QoL) was assessed using Kidney Disease Quality of Life questionnaire (KDQOL-36™), with higher scores indicating better quality of life. RESULTS The prevalence of anxiety symptoms in study sample is 64.2% and prevalence of depressive symptoms in study sample was found to be 37.5% which was significantly high. There was statistically significant association between anxiety and depressive symptoms with age of patients, gender, duration of dialysis and complication during dialysis. The five domains of KDQOL showed that mean scores of QoL in areas of mental and physical health along with effect of kidney disease on life and burden of having kidney disease were less indicating poor quality of life. Anxiety and depression were negatively correlated to all the domains of KDQOL indicating that anxiety and depressive symptoms worsened quality of life of dialysis patients. CONCLUSIONS Depressive and anxiety symptoms are significantly prevalent in patients undergoing maintenance haemodialysis which usually go un-addressed. Older patients and females were more at risk of developing depressive and anxiety symptoms. Longer periods of dialysis and complications during dialysis were also important contributors to depressive and anxiety symptoms. Quality of Life was poor in patients on dialysis, and symptoms of anxiety and depressive negatively impacted quality of life.